PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsPd0332991
Pd0332991
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
407 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Breast neoplasmsD001943EFO_0003869C506610536576265
CarcinomaD002277C80.092021534
Ovarian neoplasmsD010051EFO_0003893C5658113
Renal cell carcinomaD002292EFO_00003762617
Endometrial neoplasmsD016889EFO_00042303417
Thyroid neoplasmsD013964EFO_0003841112
Therapeutic equivalencyD01381011
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
NeoplasmsD009369C8026341862
Triple negative breast neoplasmsD064726773418
RecurrenceD01200876114
Squamous cell carcinomaD0022945102114
SarcomaD012509571114
Lung neoplasmsD008175C34.90761213
Male breast neoplasmsD018567244313
Neoplasm metastasisD009362EFO_000970855110
Squamous cell carcinoma of head and neckD0000771953618
Squamous cell neoplasmsD01830712114
Show 2 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
LymphomaD008223C85.96712
LeukemiaD007938C9510210
Pancreatic neoplasmsD010190EFO_0003860C25639
Non-small-cell lung carcinomaD002289669
MelanomaD0085453528
Non-hodgkin lymphomaD008228C85.9347
Precursor cell lymphoblastic leukemia-lymphomaD054198C91.0717
AdenocarcinomaD0002302327
Lymphoid leukemiaD007945C91717
Colorectal neoplasmsD015179447
Show 87 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients1818
SyndromeD01357733
Myelodysplastic syndromesD009190D4622
Castration-resistant prostatic neoplasmsD06412922
PreleukemiaD01128922
Erbb-2 genesD01873422
ThromboembolismD013923112
Drug therapyD00435822
ImmunotherapyD00716722
Myeloproliferative disordersD009196D47.111
Show 39 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
RadiotherapyD01187811
NeutropeniaD009503D7011
Bone diseasesD001847M89.911
Venous thromboembolismD054556EFO_0004286I7411
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name
INN
Description
Classification
Unknown
Drug class
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
Identifiers
PDB
CAS-ID
RxCUI
ChEMBL ID
ChEBI ID
PubChem CID
DrugBank
UNII ID
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
4 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use